Whistleblower Exposes C.R. Bard Kickback Scheme, Leading to $48.2M Settlement

C.R. Bard Inc., a multinational medical device company, agreed to pay $48.2 million to the federal government to settle a whistleblower lawsuit alleging illegal Medicare kickbacks. The case exposed how Bard’s urological division and its wholly owned subsidiary, ProSeed Inc., paid doctors and hospitals kickbacks to push Bard’s products at inflated prices for treating Medicare patients with prostate cancer.

Illegal Pay-for-Play Scheme Uncovered

A whistleblower represented by Wilbanks & Gouinlock (W&G) provided hundreds of key documents proving Bard’s involvement in an illegal Medicare kickback scheme. These kickbacks created improper financial incentives, leading to Medicare overbilling and violations of federal fraud laws.

Major Victory In Medicare Kickback Lawsuit

The Medicare kickback lawsuit resulted in a $48.2 million settlement, holding Bard accountable for its fraudulent financial practices. This case serves as a landmark example of how whistleblowers help expose corporate fraud in the healthcare industry.

Report Fraud at No Cost

If you have information about fraudulent practices, contact our office for a free, confidential consultation:

• Fill out our consultation form by clicking here.
• Email us at info@wilbanksgouinlock.com.
• Call (404) 842-1075, ext. 123 or 122.

This article is for informational purposes only and should not be considered legal advice.